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Purpose: The aim of the work was to prepare nitrendipne-loaded Eudragit RL 100 microspheres to 
achieve sustained release nitrendipine. 
Method: Nitrendipne-loaded Eudragit RL 100 microspheres were prepared by an emulsion-solvent 
evaporation method using ethanol/liquid paraffin system. The resultant microspheres were evaluated for 
average particle size, drug loading, in vitro drug release and release kinetics. FTIR spectrometry, 
scanning electron microscopy, differential scanning calorimetry and x-ray powder diffractometry were 
used to investigate the physical state of the drug in the microspheres.  
Result: The mean particle size of the microspheres was influenced by varying drug:polymer ratio and 
emulsifier concentration while drug loading was dependent on drug:polymer ratio. The results of FTIR 
spectrometry, differential scanning calorimetry and x-ray diffractometry indicated the stable character of 
nitrendipne in drug-loaded microspheres and also revealed absence of drug-polymer interaction. The 
drug release profiles of the microspheres at pH 1.2 showed poor drug release characteristics while at 
pH 6.8, drug release was extended over a period of 8 h; release was influenced by polymer 
concentration and particle size. Drug release followed the Higuchi model.  
Conclusion: The nitrendipine-loaded Eudragit RL 100 microspheres prepared under optimized 
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INTRODUCTION 
Microspheres are one of the particulate 
delivery systems used to achieve sustained or 
controlled drug delivery, improve 
bioavailability and stability and target drug to 
specific sites. Microspheres also offer 
advantages such as limiting fluctuation within 
a therapeutic range, reduction in side effects, 
decreased dose frequency and hence 
improved patient compliance
1,2
. The popular 
method for the encapsulation of drugs within 
water-insoluble polymers is the emulsion 
solvent evaporation method. This technique 
offers several advantages and is preferable to 
other preparation methods such as spray 
drying, sonication and homogenization 
because it requires only mild conditions such 
as ambient temperature and constant stirring. 
Thus, a stable emulsion can be formed 
without compromising the activity of the drugs. 
The Eudragits are biocompatible copolymers 
synthesized from acrylic and methacrylic acid 
esters. These polymers are well tolerated by 
the skin and have been used in the 
formulation of dosage forms especially matrix 
tablets for oral sustained release




. They have also been used in 
the microencapsulation of drugs
7, 8, 9
. Eudragit 
RL is insoluble in, but permeable to water and 
digestive juices, releasing drug by diffusion. 
Nitrendipine is an orally absorbed calcium 
antagonist with a short half-life of less than 3 
hour; the usual oral dosage regimen is 20 mg 
to be taken 2 to 3 times a day. Thus 
nitrendipine is a suitable candidate for oral 
sustained drug delivery. Therefore, the 
present study was undertaken to prepare 
sustained release microspheres of nitrendipne 
using Eudragit RL 100 by the emulsion 
solvent evaporation method. The factors 
affecting particle size, drug loading and drug 
release behavior of the microspheres were 
investigated. The physical state of the 
nitrendipne was also studied using FTIR, 




The following materials were obtained from 
the indicated suppliers and used as received: 
Eudragit RL 100 (Röhm GmbH & Co. KG, 
Darmstadt, Germany); ethanol (99%) and 
Span 80 (SD-Fine Chemical Works, Mumbai, 
India); liquid paraffin, di-sodium hydrogen 
phosphate anhydrous, potassium di-hydrogen 
phosphate, petroleum ether (40-60º C), 
hydrochloric acid and acetic acid glacial 
(Merck, Mumbai, India). nitrendipine B.P. 




Preparation of nitrendipine microspheres  
The nitrendipine loaded Eudragit RL100 
(EURL 100) microspheres were prepared by 
the emulsion solvent evaporation method. In 
this procedure, required amount of 
nitrendipine and EURL 100 dissolved in 
ethanol, was emulsified using light liquid 
paraffin (80 mL) containing the emulsifier, 
Span 80 (2% v/v). The system was stirred 
continuously using a propeller stirrer at 2000 
rpm and 38 ± 0.5 
o
C for 5 h to allow the 
complete evaporation of the solvent. 
Petroleum ether (40-60
 o
C), 100 ml, was then 
added dropwise to the liquid paraffin to harden 
the microspheres. The paraffin was decanted 
off, the microspheres were washed repeatedly 
4 times with petroleum ether (10 mL), 
collected by filtration and finally dried in a hot 
air oven at 40 
o
C for 1 h. 
The nitrendipine-loaded EURL microspheres 
were prepared using varying polymer 
concentrations (1, 2 and 3% w/v) in the 
dispersed medium (ethanol, 20 ml) with 
varying drug to polymer ratios (i.e., 1:1, 1:2, 
1:3, and 1:4,) while keeping the other 
parameter constant. The effects of process 
variables such as polymer concentration, drug 
to polymer ratio, and emulsifier concentration 
on the particle size of the microspheres, drug 
loading efficiency, and drug release were 
studied and optimized in the preliminary 
investigations. The optimum concentration of 
emulsifier was found to be 2% (v/v) and the 
same concentration was utilized for all the 
microsphere formulations.  
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Particle size analysis and morphological 
studies  
The mean particle size of the nitrendipine 
microspheres were determined by optical 
microscopy. At least 200 microspheres were 
analyzed for each preparation and the mean 
diameter was calculated. The surface 
morphology and appearance of the 
microspheres were examined by a scanning 
electron microscopy (JEOL JSM – 5200, 
Japan) operating between 5-24 kV.  The 
specimens were mounted on a metal stub 
(with double-sided adhesive tape) and coated 
under vacuum with gold in nitrogen 
atmosphere prior to observation. The 
micrographs are shown in Figure 1. 
Determination of drug loading (%)  
10 mg of the microspheres was dissolved in a 
standard flask containing absolute ethanol (10 
ml) and kept for 12 hours for complete 
digestion at room temperature. The solution 









               Table 1:  Drug loading, particle size, and in vitro drug release profiles of Nitrendipine –   loaded  






















at pH 1.2 over 
the period of 
4h 
Cumulative % 
drug release at 
pH 6.8 over the 
period of 8h 
1%    
   
E1a 1:1 50 34.46 ± 0.45 14.25 ± 6.85 45.73 ± 1.13 93.69 ± 0.95 
E1b 1:2 33.3 23.16 ± 0.34 16.94 ± 8.24 43.37 ± 1.16 90.62 ± 1.46 
E1c 1:3 25 18.29 ± 0.67 19.38 ± 9.27 41.57 ± 0.98 85.29 ± 1.65 
E1d 1:4 20 15.11 ± 0.28 21.46 ± 9.32 40.25 ± 1.34 85.03 ± 1.45 
2%       
E2a 1:1 50 36.18 ± 0.34 24.83 ± 10.21 43.16 ± 2.14 89.37 ± 1.01 
E2b 1:2 33.3 24.88 ± 0.39 26.10 ± 9.87 41.74 ± 1.82 86.57 ±0.84 
E2c 1:3 25 19.09 ± 0.75 28.34 ± 10.28 39.81 ± 1.86 81.93 ± 0.48 
E2d 1:4 20 16.30 ± 0.29 33.42 ± 12.16 38.43 ± 2.18 79.28 ± 1.47 
3%       
E3a 1:1 50 38.40 ± 0.44 35.94 ± 10.85 48.08 ± 1.64 82.65 ± 0.45 
E3b 1:2 33.3 26.53 ± 1.71 38.56 ± 11.78 38.29 ± 1.76 80.66 ± 0.93 
E3c 1:3 25 20.61 ± 0.31 41.28 ± 12.18 38.46 ± 0.98 76.97 ± 1.27 





        Figure1: Scanning electron micrograph of the nitrendipine-loaded EURL 100 microspheres prepared  
         at  1:4 drug: polymer ratio and a polymer concentration of 3% w/v. 
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retention: 11µm) and the filtrate was assayed 
spectrophotometrically for drug content at 356 
nm to compute the drug concentration from 
the standard curve 
10,11
. The drug loading (%) 
of the microspheres was calculated using the 
equations given below. 
Drug loading (%)=M actual / weight of powdered 
microspheres   x 100      
where M actual is the actual drug content in 
sample of microspheres. 
In vitro drug release studies  
Drug-release tests on the microspheres were 
carried out using a USP dissolution rate test 
apparatus Type II (Electro Lab model TDT- 
08L) for 8 h at a stirring speed of 100 rpm and 
temperature of 37 ± 0.5 °C. An amount of the 
microspheres equivalent to 20 mg of 
nitrendipine filled in a hard gelatin capsule 
(Size no.2) were placed in the dissolution 
medium containing 600 ml of phosphate buffer 
(pH 6.8) B.P. containing 0.3 % (w/v) of sodium 
dodecyl sulphate (SDS) to maintain sink 
condition for the drug. A quantity (5ml) of the 
dissolution medium was sampled at 
predetermined time intervals, and fresh 
dissolution medium was simultaneously used 
replenish the dissolution medium on each 
occasion to keep the volume constant. The 
sample was filtered through filter disc (particle 
retention: 11µm), the filtrate diluted to 10 ml 
with fresh dissolution medium and assayed 
spectrophotometrically (160 – UV - visible 
Shimadzu spectrophotometer) at 356 nm to 
determine drug concentration. The same 
procedure was used to assess drug release 
pattern in hydrochloric acid (0.1M) buffer 
solution (pH 1.2). The release kinetics of 
nitrendipine from the microspheres was 
determined using different models, viz, zero 
order, First order, Higuchi model, Peppas-
Korsmeyer and Hixon-Crowell. Kinetic 
assessment of release data was carried out 
with a program, PCP Disso v2.08 (Anant 
Ketkar).   
FTIR spectroscopic studies  
The IR spectra of the samples were recorded 
on an FTIR spectrophotometer (Perkin Elmer 
1600 series) using KBr pellet (12 mm disc), 
compressed in a  hydraulic press at 10 tons 
for 30 seconds.  
Differential scanning calorimetric analysis  
Differential scanning calorimetry (DSC) 
analysis was undertaken to characterize the 
changes, if any, during thermal exposure of 
samples. The test was carried out using a 
thermal analysis system (Mettler TA 4000 
model). Calibration with the standard (indium) 
was undertaken prior to subjecting the 
samples for study (between 30-400
 o 
C), which 
were heated at 10
o 
C/min in an aluminum pan 
under a nitrogen atmosphere while using an 
empty pan as the reference in this instrument. 
The instrument automatically calculated 
onsets of melting point and enthalpy of fusion. 
The results are shown in Figure 4.  
X-ray powder diffraction analysis  
The x-ray diffraction pattern of the samples 
were obtained using an x-ray diffractometer 
(Rich Seifert, model 3000 P) at 30 kV, 15 mA 
over a range of 10-100 2θ, using Cu Kα 
radiation wavelength of 1.5405 A
o
. In this 
technique, the cavity of the metal sample 
holder of the x-ray diffractometer was filled 
with ground sample powder and then 
smoothed out with a spatula. The results are 
shown in Figure 5. 
 
RESULTS  
Particle size and morphological 
characteristics  
Figure 1 shows the scanning electron 
photomicrograph of the surface of 
nitrendipine-loaded EURL microspheres 
having mean particle size 42.15 ± 12.34 µm. 
The particle size of the microspheres 
increased from 14.25 ± 6.85 to 42.15 ± 12.34 
µm with increasing polymer concentration 
(Table 1). Few drug crystals appeared on the 
surface of the microspheres. It was also 
observed that increasing the emulsifier 
concentration decreased the microsphere 
size.  
Drug loading of the microspheres  
Increase in the concentration of drug in the 
organic solvent resulted in an increase in the 
drug loading of the microspheres. The results 
indicate that the highest nitrendipine loading 
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of 38.40 ± 0.44 % was observed when the 
polymer concentration was 3% at a drug: 
polymer ratio of 1:1 and a stirring rate of 2000 
rpm.  
 
In vitro drug release and release kinetic 
model studies  
Figure 2 indicate that maximum drug release 
from nitrendipine-loaded microspheres at pH 
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Figure 2: Cumulative drug release of nitrendipine at pH 1.2 hydrochloric acid buffer from nitrendipine-
loaded Eudragit RL 100 microspheres prepared with 1% (E1), 2% (E2) and 3 % (E3) polymer 
concentrations and at various drug: polymer ratios. (Mean ± S.D.; n=3). Note: a, b, c and d represent drug 
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Figure 3: Cumulative drug release of nitrendipine in pH 6.8 phosphate buffer from nitrendipine-loaded 
Eudragit RL 100 microspheres prepared with 1% (E1), 2% (E2) and 3 % (E3) polymer concentrations and 
at various drug: polymer ratios. Note: a, b, c and d represent drug to polymer ratios 1:1, 1:2, 1:3 and 1:4, 
respectively. 
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Furthermore, there was no significant 
difference in drug release characteristics of 
the EURL microspheres irrespective of the 
polymer concentration and drug: polymer 
ratio. 
Figure 3 illustrates the cumulative percent 
release of nitrendipine-loaded microspheres at 
pH 6.8 over a period of 8 h. The data clearly 
show that drug release (for microspheres 
prepared at a drug polymer ratio of 1:1) 
decreased with increase in the polymer 
concentration as follows: 1, 2, and 3 % 
polymer concentrations showed 93.69 ± 
0.95%, 89.37 ± 1.01%, 82.65 ± 0.45% drug 
release, respectively. At other drug : polymer 
ratios (i.e., 1:2, 1:3, and 1:4) there was only a 
small retardation of drug release from the 
microspheres ranging from 86.57 ± 0.84% to 
73.40 ± 0.79% (see Figure 3). The EURL 
microspheres prepared at 3% polymer 
concentration showed a certain level of 
sustained release characteristics, especially 
microspheres prepared with 1:3 drug to 
polymer ratio (E3d) which released 73.40 ± 
0.79% of drug at pH 6.8 over 8 h. An initial 20-
33 % drug release was observed in all the 
microsphere formulations within the first hour 
at pH 6.8. Based on correlation coefficient (r
2
) 
data, the release pattern of nitrendipine from 
Eudragit RL microspheres fitted best to the 
Higuchi model. 
FTIR- spectroscopic studies 
FTIR of nitrendipine shows the principal peaks 
at the wave numbers of 1020.66 – 1349.17 
cm
-1
, indicating the presence of carboxyl, 
carboxylate groups, and carbonyl ester 
vibrations at 1701.64 cm
-1
, while C-H 
stretching appeared at 2991.62 – 2902.96 cm
-
1
 and NO2 group appeared between 1349.17 
and 1531.18 cm
-1
. In the IR spectra of the 
physical mixture of the formulation ingredients 
as well as those of nitrendipine-loaded EURL 
100 microspheres (E3d), the principal peaks 
for nitrendipine in the formulation, (E3d), 
appeared between 1020.66 and 1349.56 cm
-1
 
and indicates the presence of carboxyl, 
carboxylate groups and carbonyl ester 
vibration at 1701.74 cm
-1
, as well as NO2 




Therefore, the possibility of any drug polymer 
interaction is ruled out.  
Differential scanning calorimetric studies  
Figure 4 illustrates the DSC thermogram of 
nitrendipine, physical mixture of nitrendipine 
with EURL, and nitrendipine-loaded EURL 
100 microspheres (E3d). The DSC 
thermograms of the physical mixture of 
nitrendipine with Eudragit RL, on the one 
hand, and the microsphere formulation (E3d) 
on the other, produced almost similar melting 





C, respectively. However, the 
intensity of the drug fusion peak for the 
microsphere formulation was lower than that 
of the pure drug and physical mixture.  
X-ray diffraction studies 
Figure 5 illustrates the comparative X-ray 
powder diffraction pattern of nitrendipine 
alone, physical mixture of nitrendipine with 
EURL, and nitrendipine- loaded EURL 
microspheres (E3d). The x-ray dffraction 
profile of Eudragit RL polymer indicated the 
presence of a completely amorphous material; 
pure nitrendipine showed the classical 
diffractogram of the crystalline product. No 
major difference in the XRD patterns of the 
physical mixture and the drug loaded 
microspheres was noticed. However, 
decreases in the peak intensity and the 
baseline shift of the diffractogram were 
observed in the case of the nitrendipine-
loaded microspheres (E3d) when compared to 
that of the physical mixture. This is possibly 
due to the decrease in the degree of 
crystalinity of the drug following dispersal in 
the polymer matrix. 
 
DISCUSSION 
Nitrendipine-loaded Eudragit RL microspheres 
can be easily prepared by solvent evaporation 
method; the microspheres were satisfactory 
considering their size and shape. The 
microsphere size increased with increasing 
polymer concentration; this may be due to 
increasing polymer concentration that 
produced a significant increase in the 
viscosity, thus leading to an increase of the 
emulsion droplet size and finally a larger 
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microspheres size. On the other hand, 
microsphere size decreased with increasing 
emulsifier concentration. The effect of 
emulsifier concentration on the size of the 
microspheres can be explained by the higher 
stability of the dispersed droplets and less 
tendency of the droplets to coalesce upon 
collision at higher concentrations of the 
surfactant. The appearance of drug crystals 
on the surface of the microspheres may be 
attributed to high drug concentrations and 
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Figure 4: DSC thermograms of Eudragit RL100 (a); Eudragit RL100 microspheres without drug (b); 
nitrendipine (c); physical mixture of nitrendipine and Eudragit RL100 (d); and nitrendipine-loaded 
Eudragit RL100 microspheres (e).  
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Figure 5: X-ray powder diffraction patterns of Eudragit RL100 (a); Eudragit RL100 microspheres 
without drug (b); nitrendipine (c); physical mixture of nitrendipine and Eudragit RL100 (d); and 
nitrendipine-loaded Eudragit RL100 microspheres (e).  
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slow solvent removal as the drug formed a 
particulate (crystal) dispersion resulting. 
Drug loading increased with increase in the 
drug proportion of the preparation. The results 
of in vitro drug release studies showed that 
the various drug: polymer ratios and different 
polymer concentrations had a considerable 
effect on drug release pattern. The poor drug 
release and insignificant variation in the drug 
release pattern of nitrendipine-loaded 
microspheres at pH 1.2 may be attributed to 
the effect of the dissolution medium on drug 
dissolution from the microspheres. The 
microspheres prepared at a polymer 
concentration 3% showed considerable 
sustained release characteristics, especially 
microspheres prepared at a 1:3 drug: polymer 
ratio (E3d) which released 73.40 ± 0.79% of 
drug at pH 6.8 over a period of 8 h and 
showed better sustained release 
characteristics when compared with other 
microsphere types (Figure 3). This may be 
attributed to the higher polymer content which 
resulted in a larger particle size and a 
tightened polymer network and thus retarding 
drug release. The initial 20-33% of drug 
release from all the microspheres may be 
attributed to the presence of a small 
proportion of the drug on the microsphere 
surface which could have arisen from the 
diffusion of the drug during preparation and 
drying. When such microspheres are 
immersed in dissolution medium, the surface 
drug is immediately released. The 
assessment of the release kinetics revealed 
that drug release from the microspheres at pH 
6.8 phosphate buffer followed the Higuchi 
model. The DSC thermographs of the 
microspheres showed that the drug fusion 
peak intensity was less than those for the pure 
drug and the physical mixture. This may be 
due to the reduced drug content, (arising from 
homogeneous dissolution of the drug in the 
polymer. Other tests indicate that nitrendipine 
remained in a crystalline state with in the 
polymer network of the microsphere. It is 
clearly evident from the XRD pattern, 
however, that lower peak intensity and a 
baseline shift were observed for the 
microsphere when compared to that of the 
physical mixture. This may be due to a 




From the foregoing investigations it was 
concluded that the nitrendipine loaded 
Eudragit RL microspheres under optimized 
conditions showed some degree sustained 
release and were stable under the conditions 
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